申请人:Dack Kevin Neil
公开号:US20080280877A1
公开(公告)日:2008-11-13
The invention relates to EP2 antagonist azetidines of formula (I)
wherein Ar, R
1
, X, and Z are as defined herein, to their use in medicine, particularly in the treatment of endometriosis and/or uterine fibroids, to intermediates useful in their synthesis, and to compositions containing them.
这项发明涉及到式(I)的EP2拮抗剂氮杂环丁烷,其中Ar、R1、X和Z如本文所定义,其在医学上的应用,特别是在子宫内膜异位症和/或子宫肌瘤的治疗中的应用,以及其合成中有用的中间体,以及含有它们的组合物。